Trials / Sponsors / Li-kun Chen
Li-kun Chen
Academic / Other · 4 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Sacituzumab Tirumotecan (Sac-TMT) Plus Bevacizumab in 3rd Generation EGFR-TKI Treated Advanced EGFR-mutant Non Lung Cancer | Phase 2 | 2025-10-01 |
| Recruiting | Efficacy and Safety of Vorolanib Monotherapy As Third-line or Later Treatment for Advanced Non-small Cell Lung Advanced Non-small Cell Lung Cancer (NSCLC), Recurrent or Metastatic Lung Cancer, Third-line and Beyond Therapy | Phase 2 | 2024-12-01 |
| Recruiting | Evaluation of the Efficacy and Safety of Furmonertinib Combined with Bevacizumab As First-Line Treatment for E Non-small Cell Lung Cancer (NSCLC), EGFR Mutation-Positive Lung Cancer, Brain Metastases | Phase 2 | 2024-09-04 |
| Unknown | the Efficacy and Safety of Anlotinib Combined With Almonertinib in the First-line Treatment of Patients With B Non-small Cell Lung Cancer, Brain Metastases | Phase 2 | 2021-05-01 |